Abstract:Background Resuscitation with blood products is often required for pediatric cardiac surgery patients following cardiopulmonary bypass. However, data suggests that blood product transfusion is an independent predictor of adverse outcomes. Most studies have specifically found detrimental effects of overall transfusion of red blood cells in particular, but few have analyzed outcomes by the other specific blood product components. Aims The objective of this study is to analyze adverse outcomes associated with intraoperative transfusion of specific blood product components. Methods A retrospective review was performed on 643 pediatric patients who underwent cardiac surgery requiring cardiopulmonary bypass to evaluate the risk of selected adverse outcomes associated with intraoperative blood product transfusion. Adverse outcomes included thrombotic complications, stroke, acute kidney injury, prolonged mechanical ventilation, and death. Univariate logistic and linear regression analyses were performed to explore the association between various blood products and the occurrence of postoperative complications. Multiple logistic and linear regression analyses were performed adjusting for age, cyanotic status, STAT score, and cardiopulmonary bypass time. Results Unadjusted analysis using univariate logistic and linear regressions showed statistically significant associations of almost all blood components (per 10 ml/kg dose increments) with multiple postoperative complications, including mortality, thrombotic complications, stroke, and days of mechanical ventilation. After adjusting for patient age, cyanotic status, STAT score, and CPB time, multivariable logistic and linear regression analyses revealed no association between transfusion of blood products with acute kidney injury and stroke. Administration of RBCs was the only category significantly correlated with increased days of mechanical ventilation (0.5 days increase of mechanical ventilation per 10 ml/kg transfusion of RBCs). The only blood product to show complete lack of a statistically significant association with any of the studied outcomes was cryoprecipitate. Conclusions Transfusion of blood products following cardiopulmonary bypass is associated with postoperative adverse outcomes. Future studies aimed at strategies to reduce intraoperative bleeding and decrease the amount of blood products administered are warranted.

Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass

Whole blood: total blood product ratio impacts survival in injured children

Safety profile of low-titer group O whole blood in pediatric patients with massive hemorrhage

Review of Low Titer Group O Whole Blood (LTOWB) Transfusion in Initial Resuscitation of Pediatric Trauma Patients: Assessing Potential Benefits

The Characteristics of Blood Transfusion and Analysis of Preoperative Factors Associated with Intraoperative Blood Transfusion in Congenital Heart Surgery: a Case–control Study

A survey of low titer O whole blood use within the trauma quality improvement program registry

Retrospective Cohort Analysis of Associations Between Blood Transfusion and Postoperative Lung Injury after Cardiac Surgery

Effects of Circuit Residual Volume Salvage Reinfusion on the Postoperative Clinical Outcome for Pediatric Patients Undergoing Cardiac Surgery

An analysis of the effect of low titer O whole blood (LTOWB) proportions for resuscitation after trauma on 6-hour and 24-hour survival

Resuscitative practices and the use of low-titer group O whole blood in pediatric trauma

The Efficacy of Low-Titer Group O Whole Blood Compared With Component Therapy in Civilian Trauma Patients: A Meta-Analysis

Application of thromboelastography for children undergoing cardiac surgery with cardiopulmonary bypass

Application of Modified Ultrafiltration on Cardiopulmonary Bypass in Children

Maternal and child life years gained by transfusing low titer group O whole blood in trauma: A computer simulation

Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children

Intraoperative blood product transfusion in pediatric cardiac surgery patients: a retrospective review of adverse outcomes

Effects of Miniaturization of Cardiopulmonary Bypass Circuits on Blood Transfusion Requirement in Neonatal and Infant Open Heart Surgery

Early experience with transfusing low titer group O whole blood in the pre‐hospital setting in Israel

Type-specific whole blood still has a role in the era of low titer O universal donor transfusion for severe trauma hemorrhage

Low-Titer Group O Whole-Blood Resuscitation in the Prehospital Setting in Israel: Review of the First 2.5 Years’ Experience

Comparative outcomes of cardioplegic arrest versus beating heart in pediatric undergoing extracardiac total cavopulmonary connection